Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

Launched by LOMA LINDA UNIVERSITY · Aug 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective and safe it is to give children with Iron Deficiency Anemia (IDA) iron supplements every day compared to giving them every other day. IDA is a common health issue where the body doesn't have enough iron, which is important for making red blood cells that carry oxygen. By exploring different ways to provide iron, the researchers hope to find a method that not only helps children feel better but is also easier for them to take without side effects.

To participate in this trial, children aged 1 to 18 years who have confirmed IDA can join. It's important that they are able and willing to take iron supplements, either in tablet or liquid form. However, some children won't be eligible, such as those who are pregnant or breastfeeding, have allergies to iron, or certain other health conditions like inflammatory bowel disease or cancer. The trial is not yet recruiting participants, but when it does, families can expect their child to receive either the daily or every-other-day iron and be monitored for improvements and any side effects. This study could provide valuable information that helps improve treatment for children with IDA.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed Iron Deficiency Anemia
• • Pediatric patients (1-18 years of age) without regard of gender, race, ethnicity nor language.
• • Able and willing to take oral iron (tablet or liquid).
• Exclusion Criteria:
• • Pregnant or lactating patients
• • Known allergies or intolerance to oral iron formulations
• • Concomitant chronic medical conditions affecting iron metabolism
• • Short gut syndrome
• • Celiac disease
• • Inflammatory bowel disease
• • Cancer
• • Chronic kidney disease
• • Blood transfusions in the past 3 months
• • IV iron administration in the past 3 months
• • Oral iron supplementation in the past 2 weeks